Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 9
2005 4
2006 4
2007 3
2008 3
2009 4
2010 2
2011 9
2012 6
2013 5
2014 8
2015 10
2016 2
2017 6
2018 2
2019 2
2020 4
2021 6
2022 8
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Repertoire of morphable proteins in an organism.
Izumi K, Saho E, Kutomi A, Tomoike F, Okada T. Izumi K, et al. PeerJ. 2020 Feb 11;8:e8606. doi: 10.7717/peerj.8606. eCollection 2020. PeerJ. 2020. PMID: 32095378 Free PMC article.
Dropped head in systemic sclerosis: a case based review.
Shimada T, Higashida-Konishi M, Akiyama M, Hama S, Takei H, Izumi K, Oshima H, Okano Y. Shimada T, et al. Among authors: izumi k. Rheumatol Int. 2022 Aug;42(8):1483-1489. doi: 10.1007/s00296-021-04942-z. Epub 2021 Jul 5. Rheumatol Int. 2022. PMID: 34223951 Review.
Subjective well-being and month-long LF/HF ratio among deskworkers.
Shiga K, Izumi K, Minato K, Sugio T, Yoshimura M, Kitazawa M, Hanashiro S, Cortright K, Kurokawa S, Momota Y, Sado M, Maeno T, Takebayashi T, Mimura M, Kishimoto T. Shiga K, et al. Among authors: izumi k. PLoS One. 2021 Sep 7;16(9):e0257062. doi: 10.1371/journal.pone.0257062. eCollection 2021. PLoS One. 2021. PMID: 34492071 Free PMC article.
Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial.
Tamai H, Ikeda K, Miyamoto T, Taguchi H, Kuo CF, Shin K, Hirata S, Okano Y, Sato S, Yasuoka H, Kuwana M, Ishii T, Kameda H, Kojima T, Taninaga T, Mori M, Miyagishi H, Sato Y, Tsai WC, Takeuchi T, Kaneko Y; MIRACLE study collaborators. Tamai H, et al. Lancet Rheumatol. 2023 Apr;5(4):e215-e224. doi: 10.1016/S2665-9913(23)00070-X. Lancet Rheumatol. 2023. PMID: 38251524 Clinical Trial.
Allergic disorders and their risk factors in primary Sjögren's syndrome.
Higashida-Konishi M, Izumi K, Shimada T, Hama S, Oshige T, Oshima H, Okano Y. Higashida-Konishi M, et al. Among authors: izumi k. World Allergy Organ J. 2023 Jan 27;16(2):100745. doi: 10.1016/j.waojou.2023.100745. eCollection 2023 Feb. World Allergy Organ J. 2023. PMID: 36788991 Free PMC article.
Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement.
Higashida-Konishi M, Izumi K, Tsukamoto M, Ohya H, Takasugi N, Hama S, Hayashi Y, Ushikubo M, Akiya K, Kazuhiro A, Okano Y, Oshima H. Higashida-Konishi M, et al. Among authors: izumi k. Clin Rheumatol. 2020 Aug;39(8):2441-2448. doi: 10.1007/s10067-020-05044-0. Epub 2020 Apr 30. Clin Rheumatol. 2020. PMID: 32356228 Review.
100 results